150 related articles for article (PubMed ID: 15767744)
1. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.
Cebrián L; Rodríguez JC; Escribano I; Royo G
Chemotherapy; 2005 Mar; 51(1):40-3. PubMed ID: 15767744
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
[TBL] [Abstract][Full Text] [Related]
3. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
4. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Levy DD; Sharma B; Cebula TA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
[TBL] [Abstract][Full Text] [Related]
5. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
Preisler A; Heisig P
J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
7. The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp.
Escribano I; Rodríguez JC; Cebrian L; Royo G
Int J Antimicrob Agents; 2004 Nov; 24(5):428-32. PubMed ID: 15519472
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of gene expression associated with both the AcrAB/TolC system and the membrane permeability, in Salmonella spp isolates with and without gyrA mutation].
Galiana A; Sánchez-Guillén L; Rodríguez JC; Cremades R; Santibañez M; Ferrari R; Ruiz-García M; López P; Royo G
Rev Esp Quimioter; 2014 Dec; 27(4):239-43. PubMed ID: 25536427
[TBL] [Abstract][Full Text] [Related]
9. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones.
Rodriguez-Avial I; Rodriguez-Avial C; López O; Picazo JJ
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):261-4. PubMed ID: 15893900
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.
Cebríán L; Rodríguez JC; Escribiano I; Royo SG
APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
12. [Decrease in bactericidal activity of ciprofloxacin in Salmonella mutants generated following repeated exposure to various fluorquinolones].
Cebrián L; Rodríguez JC; Escribano I; Ruiz M; Royo G
Rev Esp Quimioter; 2006 Dec; 19(4):363-6. PubMed ID: 17235406
[TBL] [Abstract][Full Text] [Related]
13. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
14. Effect of exposure to fluoroquinolones and beta-lactams on the in vitro activity of other groups of antibiotics in Salmonella spp.
Cebrian L; Rodríguez JC; Escribano I; Royo G
APMIS; 2006; 114(7-8):523-8. PubMed ID: 16907858
[TBL] [Abstract][Full Text] [Related]
15. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.
Yan M; Sahin O; Lin J; Zhang Q
J Antimicrob Chemother; 2006 Dec; 58(6):1154-9. PubMed ID: 17023497
[TBL] [Abstract][Full Text] [Related]
16. Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005.
Akiba M; Nakaoka Y; Kida M; Ishioka Y; Sameshima T; Yoshii N; Nakazawa M; Uchida I; Terakado N
J Antimicrob Chemother; 2007 Dec; 60(6):1235-42. PubMed ID: 17956907
[TBL] [Abstract][Full Text] [Related]
17. Recognition of mechanisms involved in bile resistance important to halting antimicrobial resistance in nontyphoidal Salmonella.
Tsai MH; Wu SR; Lee HY; Chen CL; Lin TY; Huang YC; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):151-7. PubMed ID: 22743016
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the gyrA and parC genes in Salmonella spp. following in vitro exposure to fluoroquinolones.
Cebrian L; Escribano I; Rodriguez JC; Royo G
J Chemother; 2006 Jun; 18(3):250-4. PubMed ID: 17129834
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.
Lunn AD; Fàbrega A; Sánchez-Céspedes J; Vila J
Int Microbiol; 2010 Mar; 13(1):15-20. PubMed ID: 20890836
[TBL] [Abstract][Full Text] [Related]
20. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
Escribano I; Rodríguez JC; Llorca B; García-Pachon E; Ruiz M; Royo G
Chemotherapy; 2007; 53(6):397-401. PubMed ID: 17934259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
